Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

4.05
Delayed Data
As of Jun 27
 +0.05 / +1.25%
Today’s Change
1.10
Today|||52-Week Range
5.30
+200.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues6.6M10.2M18.0M27.0M
 
 
 
 
 
Cost of Goods Sold4.6M7.6M12.4M14.7M
 
 
 
 
 
Depreciation And Amortization326.5K838.6K1.7M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income1.7M1.7M3.9M9.9M
 
 
 
 
 
General Expenses9.5M20.0M23.9M26.6M
 
 
 
 
 
Research And Development2.2M3.7M4.8M5.9M
 
 
 
 
 
Total Operating Expenses14.5M28.5M38.0M43.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.8M-18.3M-20.0M-16.7M
 
 
 
 
 
Extraordinary Credit4.6M615.0K511.0K1.7M
 
 
 
 
 
Extraordinary Charge-7.5M0.00-890.0K0.00
 
 
 
Pre-Tax Equity Earnings---939.9K-707.0K-73.0K
 
 
 
 
Interest Expense On Debt2.4M472.8K344.0K454.0K
 
 
 
 
 
Other Expenses0.000.000.00-325.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.0M-19.0M-21.4M-15.8M
 
 
 
 
 
Income Taxes-663.9K-2.4M-1.2M0.00
 
 
 
 
Net Income-12.4M-16.6M-20.2M-15.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.7M9.4M10.3M15.9M
 
 
 
 
 
Shares To Calculate EPS Diluted4.7M9.5M10.3M15.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.64-$1.80-$1.96-$1.00
 
 
 
 
 
EPS Diluted-$3.64-$1.80-$1.96-$1.00